EU Antitrust Probe Threatens Mars-Kellanova Merger; FDA Redefines 'Healthy'
The European Commission's in-depth antitrust investigation into Mars' Kellanova acquisition signals heightened M&A scrutiny in Europe, with a decision due by 31 October. Concurrently, the FDA is revamping its 'healthy' food definition and pushing for clearer front-of-pack nutrition labels in the US.
London, United Kingdom — 27 June 2025
The proposed $36 billion acquisition of Kellanova by Mars faces significant European Union scrutiny, despite US Federal Trade Commission clearance. The European Commission has initiated an in-depth antitrust probe, expressing concerns that the combined entity could substantially reduce competition within the snack foods sector, specifically affecting cereal bars, biscuits, and fruit snacks. This investigation follows a preliminary review suggesting the merger could confer disproportionate buying power on Mars, leading to elevated consumer prices and restricted retail choice. A definitive decision deadline is set for 31 October, with potential requirements for Mars to divest specific assets.
Simultaneously, the US Food and Drug Administration (FDA) is progressing with critical nutrition policy reforms. A key initiative involves revising the definition of 'healthy' on food packaging. The updated criteria will permit nutrient-dense whole foods, such as avocados and nuts, to qualify, while restricting high-sodium or high-sugar products. This move aims to modernise labelling standards and promote healthier consumer choices.
Further FDA plans include leveraging Artificial Intelligence for chemical safety assessments and advancing front-of-pack nutrition labels to highlight added sugars, saturated fats, and sodium. The agency also intends to phase out synthetic colour Red No. 3, which remains permissible in food despite being banned in cosmetics for decades. These reforms underscore a concerted effort to enhance food safety and provide clearer nutritional information to American consumers. Meanwhile, scientific consensus continues to refute misinformation regarding seed oils, reaffirming their safety and potential heart health benefits, challenging pervasive social media narratives.
What this means for United Kingdom
UK supplement manufacturers and brand owners should monitor the EU’s M&A enforcement, as similar scrutiny could extend to contract manufacturing consolidation or ingredient supply chain mergers that impact European markets. While the FDA’s 'healthy' definition change is US-specific, it signals a global trend towards stricter nutritional claims, prompting UK brands to proactively review their own product formulations and marketing claims for alignment with evolving consumer and regulatory expectations. Compliance leads should anticipate potential demand for cleaner label ingredients and reduced sugar/sodium content in co-manufactured products, influencing procurement and R&D pipelines. The eventual outcome of the Mars-Kellanova deal will dictate potential shifts in ingredient availability and pricing for snack-related components.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.